These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 17848356)

  • 1. Annual influenza immunization: as important as control of blood pressure and cholesterol as secondary prevention for cardiovascular disease.
    Grajewski J; Slusar M; Hayney MS
    J Am Pharm Assoc (2003); 2007; 47(5):662-3. PubMed ID: 17848356
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cardiovascular prevention: not necessary under the age of 40].
    Walma EP
    Ned Tijdschr Geneeskd; 2009; 153():B351. PubMed ID: 19785804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular protection paradigms: is change on the horizon?
    Papademetriou V
    Rev Cardiovasc Med; 2007; 8(4):200-13. PubMed ID: 18192943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The new cardiovascular disease prevention guidelines: what you need to know.
    Campos-Outcalt D
    J Fam Pract; 2014 Feb; 63(2):89-93. PubMed ID: 24527471
    [No Abstract]   [Full Text] [Related]  

  • 5. World Hypertension Day 2007.
    Jones DW; Hall JE
    Hypertension; 2007 May; 49(5):939-40. PubMed ID: 17420339
    [No Abstract]   [Full Text] [Related]  

  • 6. [CBO guideline 'high blood pressure' (revision)].
    de Bruijckere PA
    Ned Tijdschr Geneeskd; 2002 Mar; 146(9):439; author reply 439. PubMed ID: 11901947
    [No Abstract]   [Full Text] [Related]  

  • 7. [CBO guideline 'high blood pressure' (revision)].
    Polak BC
    Ned Tijdschr Geneeskd; 2002 Mar; 146(9):439; author reply 439-40. PubMed ID: 11901948
    [No Abstract]   [Full Text] [Related]  

  • 8. Blood pressure and antihypertensive therapy according to the global cardiovascular risk level in Italy: the CHECK Study.
    Filippi A; Casula M; Tragni E; Brignoli O; Cricelli C; Poli A; Catapano AL;
    Eur J Cardiovasc Prev Rehabil; 2010 Oct; 17(5):562-8. PubMed ID: 20308908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic factors in formulating a national policy on the prevention by drugs of cardiovascular disease.
    Malcolm L
    N Z Med J; 1990 Aug; 103(896):402-4. PubMed ID: 2117264
    [No Abstract]   [Full Text] [Related]  

  • 10. Statins in hypertension: are they a new class of antihypertensive agents?
    Feldstein CA
    Am J Ther; 2010; 17(3):255-62. PubMed ID: 19918164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 2013 ACC/AHA Cholesterol Management Guideline: Clearing the Confusion from Noncontroversial Components.
    Virani SS
    Tex Heart Inst J; 2016 Aug; 43(4):313-4. PubMed ID: 27547139
    [No Abstract]   [Full Text] [Related]  

  • 12. Intermittent claudication: a plea for guidelines for medical management.
    Powell JT
    Eur J Vasc Endovasc Surg; 2007 Apr; 33(4):451-2. PubMed ID: 17196850
    [No Abstract]   [Full Text] [Related]  

  • 13. Rational prescribing in primary care (RaPP): a cluster randomized trial of a tailored intervention.
    Fretheim A; Oxman AD; Håvelsrud K; Treweek S; Kristoffersen DT; Bjørndal A
    PLoS Med; 2006 Jun; 3(6):e134. PubMed ID: 16737346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol goal attainment in hypertensive patients: the impact of metabolic syndrome components.
    Rodrigues CJ; Ribeiro HF; Ribeiro AB; Zanella MT; Batista MC
    Metab Syndr Relat Disord; 2012 Jun; 10(3):195-201. PubMed ID: 22313142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing diabetes care regarding cardiovascular targets at general practice level: Direct@GP.
    Wens J; Gerard R; Vandenberghe H
    Prim Care Diabetes; 2011 Apr; 5(1):19-24. PubMed ID: 21030327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Type 2 diabetes and cardiovascular risk: lessons from therapeutic trials].
    Lièvre M
    Rev Prat; 2001 Oct; 51(16):1793-9. PubMed ID: 11795124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Monitoring drug adherence for hypertensive and dyslipidemic patients in networks of community-based pharmacists and physicians].
    Santschi V; Rodondi N; Bugnon O; Pannatier A; Burnier M
    Rev Med Suisse; 2008 Sep; 4(170):1928, 1930-2, 1934 passim. PubMed ID: 18847122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New cholesterol guidelines emphasize risk assessment.
    Grundy SM
    Am J Manag Care; 2002 Jan; Suppl():1, 3. PubMed ID: 11833450
    [No Abstract]   [Full Text] [Related]  

  • 19. IMPROVE-IT clinical implications. Should the "high-intensity cholesterol-lowering therapy" strategy replace the "high-intensity statin therapy"?
    Masana L; Pedro-Botet J; Civeira F
    Atherosclerosis; 2015 May; 240(1):161-2. PubMed ID: 25795557
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of risk factors among ambulatory patients at high cardiovascular risk in Canada: a follow-up study.
    Elbarasi EA; Goodman SG; Yan RT; Tan MK; Hackam DG; Leiter LA; Langer A; Yan AT;
    Can J Cardiol; 2013 Dec; 29(12):1586-92. PubMed ID: 24041994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.